10.61 million is the present research & development by business enterprise, pharmaceutical industry in constant ppp $ value in Latvia, reflecting an increase of 1.88 million (21.5%) since 2020.
Research & development by business enterprise, pharmaceutical industry in constant PPP $ in Latvia
No matching regions
Similar regions to Latvia
More indicators for Latvia
Government R&D in security as % of government support
1.61%
-1.01%
(2021)
R&D financed by rest of the world in local currency
756.98M
+64.87M
(2021)
Government R&D financed by rest of the world in local currency
221.75M
+55.75M
(2021)
Business R&D financed by rest of the world in local currency
201.76M
+46.65M
(2021)
Non-profit R&D growth rate
-100%
0%
(2006)
Latvia Business R&D pharmaceutical in constant PPP $ between 2008 and 2021
| Period | Value | Change |
|---|---|---|
| 2021 | 10.61M | +1.88M |
| 2020 | 8.74M | +0.23M |
| 2019 | 8.51M | +0.05M |
| 2018 | 8.46M | +0.44M |
| 2017 | 8.01M | +2.53M |
| 2016 | 5.48M | +0.05M |
| 2015 | 5.43M | -0.01M |
| 2014 | 5.43M | -6.05M |
| 2013 | 11.48M | +1.26M |
| 2012 | 10.22M | +2.03M |
| 2010 | 8.19M | -1.84M |
| 2008 | 10.03M |